PRME
Price
$4.42
Change
+$0.13 (+3.02%)
Updated
Apr 26, 6:59 PM EST
13 days until earnings call
XNCR
Price
$19.98
Change
+$0.75 (+3.90%)
Updated
Apr 26, 6:59 PM EST
13 days until earnings call
Ad is loading...

Compare trend and price PRME vs XNCR

Header iconPRME vs XNCR Comparison
Open Charts PRME vs XNCRBanner chart's image
Prime Medicine
Price$4.42
Change+$0.13 (+3.02%)
Volume$422.76K
CapitalizationN/A
Xencor
Price$19.98
Change+$0.75 (+3.90%)
Volume$210.7K
CapitalizationN/A
View a ticker or compare two or three
PRME vs XNCR Comparison Chart

Loading...

PRMEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
XNCRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
PRME vs. XNCR commentary
Apr 27, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRME is a Hold and XNCR is a Hold.

COMPARISON
Comparison
Apr 27, 2024
Stock price -- (PRME: $4.30 vs. XNCR: $19.23)
Brand notoriety: PRME and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PRME: 127% vs. XNCR: 69%
Market capitalization -- PRME: $530.73M vs. XNCR: $1.23B
PRME [@Biotechnology] is valued at $530.73M. XNCR’s [@Biotechnology] market capitalization is $1.23B. The market cap for tickers in the [@Biotechnology] industry ranges from $556.22B to $0. The average market capitalization across the [@Biotechnology] industry is $2.55B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRME’s FA Score shows that 0 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • PRME’s FA Score: 0 green, 5 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, XNCR is a better buy in the long-term than PRME.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRME’s TA Score shows that 4 TA indicator(s) are bullish while XNCR’s TA Score has 5 bullish TA indicator(s).

  • PRME’s TA Score: 4 bullish, 4 bearish.
  • XNCR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both PRME and XNCR are a good buy in the short-term.

Price Growth

PRME (@Biotechnology) experienced а -6.32% price change this week, while XNCR (@Biotechnology) price change was +1.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.51%. For the same industry, the average monthly price growth was -3.37%, and the average quarterly price growth was +1265.61%.

Reported Earning Dates

PRME is expected to report earnings on May 09, 2024.

XNCR is expected to report earnings on Jul 31, 2024.

Industries' Descriptions

@Biotechnology (+7.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for PRME with price predictions.
OPEN
A.I.dvisor published
a Summary for XNCR with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
XNCR($1.23B) has a higher market cap than PRME($516M). XNCR YTD gains are higher at: -9.421 vs. PRME (-51.467).
PRMEXNCRPRME / XNCR
Capitalization516M1.23B42%
EBITDAN/AN/A-
Gain YTD-51.467-9.421546%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
XNCR: Fundamental Ratings
XNCR
OUTLOOK RATING
1..100
57
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
6
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PRMEXNCR
RSI
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
64%
Bullish Trend 2 days ago
68%
Declines
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 5 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
65%
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
74%
View a ticker or compare two or three
Ad is loading...
PRMEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
XNCRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MFCIX35.510.06
+0.17%
Meridian Contrarian Investor
BROCX17.67-0.10
-0.56%
BlackRock Advantage International Inv C
VASVX29.21-0.20
-0.68%
Vanguard Selected Value Inv
DTSVX25.04-0.28
-1.11%
Wilshire Small Company Value Invmt
TSVCX11.02-0.16
-1.43%
Timothy Plan Small Cap Value C

PRME and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRME has been loosely correlated with BEAM. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if PRME jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRME
1D Price
Change %
PRME100%
-8.51%
BEAM - PRME
63%
Loosely correlated
-5.01%
NTLA - PRME
61%
Loosely correlated
-5.43%
RLAY - PRME
54%
Loosely correlated
-3.07%
XNCR - PRME
53%
Loosely correlated
+1.10%
ABCL - PRME
50%
Loosely correlated
-6.92%
More

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with BEAM. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
+1.10%
BEAM - XNCR
54%
Loosely correlated
-5.01%
VCYT - XNCR
52%
Loosely correlated
-2.11%
PRME - XNCR
52%
Loosely correlated
-8.51%
NTLA - XNCR
51%
Loosely correlated
-5.43%
DNLI - XNCR
51%
Loosely correlated
-3.86%
More